NovaBay Pharmaceuticals Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Going Beyond Antibiotics® Developing Anti-Infective Compounds Effective Against Bacteria, Viruses and Fungi. NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company developing products for the eye care market. We are currently focused primarily on commercializing prescription Avenova® for managing hygiene of the eyelids and lashes in the United States. Avenova is the only eye care product formulated with a proprietary, stable and pure form of hypochlorous acid called Neutrox®. By repView more